Gain Therapeutics, Inc. (GANX) financial statements and ratios from SEC XBRL: revenue $55180.00 (TTM), net margin -40354.3%. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $55180.00 |
| Net Margin | -40354.3% |
| Price / Book | 7.73 |
| Sector P/E (Healthcare) | 21.7 |
GANX overview · GANX earnings · GANX KPIs · GANX investor relations · GANX ownership · GANX peers · GANX filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.